Changes in hepatic fibrosis and vitamin D levels after viral hepatitis C eradication using direct-acting antiviral therapy

BMC Gastroenterology

Yong Poovorawan¹  Nunthiya Srisoonthorn²  Nattaporn Tanpowpong³  Bundit Chaopathomkul³  Nicha Teeratorn⁴  Sombat Treeprasertsuk⁴  Kanokwan Sonsiri⁴  Panarat Thaimai⁴  Sukanya Sittisomwong⁴  Supachaya Sriphoosanaphan⁵  Kessarin Thanapirom⁶  Piyawat Komolmit⁶  Sirinporn Suksawatamnuay⁶ 

[1] Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand;Center of Excellence in Liver Diseases, King Chulalongkorn Memorial Hospital, Thai Red Cross, Bangkok, Thailand;Department of Radiology, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand;Division of Gastroenterology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand;Division of Gastroenterology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand;Center of Excellence in Liver Diseases, King Chulalongkorn Memorial Hospital, Thai Red Cross, Bangkok, Thailand;Division of Gastroenterology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand;Center of Excellence in Liver Diseases, King Chulalongkorn Memorial Hospital, Thai Red Cross, Bangkok, Thailand;Liver Fibrosis and Cirrhosis Research Unit, Chulalongkorn University, Bangkok, Thailand;

关键词: Vitamin D;    Hepatitis C;    Liver fibrosis;    Direct-acting antiviral;    Amino terminal of type III procollagen peptide;   

DOI  :  10.1186/s12876-020-01485-8

来源: Springer

【 授权许可】

CC BY